[{"Assets_0_Q1_USD":175203000.0,"CommonStockSharesOutstanding_0_Q1_shares":270695420.0,"EarningsPerShareBasic_1_Q1_USD":-0.08,"EarningsPerShareDiluted_1_Q1_USD":-0.08,"NetIncomeLoss_1_Q1_USD":-20941000.0,"StockholdersEquity_0_Q1_USD":-28769000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":270163000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":270163000.0,"Ticker":"AMRN","CIK":"897448","name":"AMARIN CORP PLC\\UK","OfficialName":"Amarin Corporation plc","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265593617.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170503"}]